178 related articles for article (PubMed ID: 25054967)
21. Bradykinin mediated gastrointestinal edema as a cause of abdominal attacks in patients with hereditary angioedema due to C1-inhibitor deficiency.
Obtulowicz P; Piotrowicz-Wojcik K; Dyga W; Stobiecki M; Popiela T; Obtulowicz K
J Physiol Pharmacol; 2022 Apr; 73(2):. PubMed ID: 36193964
[TBL] [Abstract][Full Text] [Related]
22. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.
Cicardi M; Banerji A; Bracho F; Malbrán A; Rosenkranz B; Riedl M; Bork K; Lumry W; Aberer W; Bier H; Bas M; Greve J; Hoffmann TK; Farkas H; Reshef A; Ritchie B; Yang W; Grabbe J; Kivity S; Kreuz W; Levy RJ; Luger T; Obtulowicz K; Schmid-Grendelmeier P; Bull C; Sitkauskiene B; Smith WB; Toubi E; Werner S; Anné S; Björkander J; Bouillet L; Cillari E; Hurewitz D; Jacobson KW; Katelaris CH; Maurer M; Merk H; Bernstein JA; Feighery C; Floccard B; Gleich G; Hébert J; Kaatz M; Keith P; Kirkpatrick CH; Langton D; Martin L; Pichler C; Resnick D; Wombolt D; Fernández Romero DS; Zanichelli A; Arcoleo F; Knolle J; Kravec I; Dong L; Zimmermann J; Rosen K; Fan WT
N Engl J Med; 2010 Aug; 363(6):532-41. PubMed ID: 20818888
[TBL] [Abstract][Full Text] [Related]
23. Open-label, multicenter study of self-administered icatibant for attacks of hereditary angioedema.
Aberer W; Maurer M; Reshef A; Longhurst H; Kivity S; Bygum A; Caballero T; Bloom B; Nair N; Malbrán A
Allergy; 2014 Mar; 69(3):305-14. PubMed ID: 24438203
[TBL] [Abstract][Full Text] [Related]
24. A randomized trial of icatibant in ACE-inhibitor-induced angioedema.
Baş M; Greve J; Stelter K; Havel M; Strassen U; Rotter N; Veit J; Schossow B; Hapfelmeier A; Kehl V; Kojda G; Hoffmann TK
N Engl J Med; 2015 Jan; 372(5):418-25. PubMed ID: 25629740
[TBL] [Abstract][Full Text] [Related]
25. How satisfactory is on-demand icatibant from the patients' perspective in real life?
Beyaz S; Demir S; Oztop N; Colakoglu B; Buyukozturk S; Gelincik A
Allergy Asthma Proc; 2022 Mar; 43(2):148-154. PubMed ID: 35317892
[No Abstract] [Full Text] [Related]
26. Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.
Longhurst HJ; Zanichelli A; Caballero T; Bouillet L; Aberer W; Maurer M; Fain O; Fabien V; Andresen I;
Clin Exp Immunol; 2017 Apr; 188(1):148-153. PubMed ID: 27936514
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of icatibant self-administration for acute hereditary angioedema.
Boccon-Gibod I; Bouillet L
Clin Exp Immunol; 2012 Jun; 168(3):303-7. PubMed ID: 22519593
[TBL] [Abstract][Full Text] [Related]
28. The Icatibant Outcome Survey: 10 years of experience with icatibant for patients with hereditary angioedema.
Maurer M; Aberer W; Caballero T; Bouillet L; Grumach AS; Botha J; Andresen I; Longhurst HJ;
Clin Exp Allergy; 2022 Sep; 52(9):1048-1058. PubMed ID: 35861129
[TBL] [Abstract][Full Text] [Related]
29. Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment.
Maurer M; Aberer W; Bouillet L; Caballero T; Fabien V; Kanny G; Kaplan A; Longhurst H; Zanichelli A;
PLoS One; 2013; 8(2):e53773. PubMed ID: 23390491
[TBL] [Abstract][Full Text] [Related]
30. Bradykinin B2 receptor antagonist off label use in short-term prophylaxis in hereditary angioedema.
Angeletti C; Angeletti PM; Mastrobuono F; Pilotti L; Ciccozzi A; Guetti C
Int J Immunopathol Pharmacol; 2014; 27(4):653-9. PubMed ID: 25572747
[TBL] [Abstract][Full Text] [Related]
31. Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema.
Straka BT; Ramirez CE; Byrd JB; Stone E; Woodard-Grice A; Nian H; Yu C; Banerji A; Brown NJ
J Allergy Clin Immunol; 2017 Jul; 140(1):242-248.e2. PubMed ID: 27913306
[TBL] [Abstract][Full Text] [Related]
32. Costs and effects of on-demand treatment of hereditary angioedema in Italy: a prospective cohort study of 167 patients.
Federici C; Perego F; Borsoi L; Crosta V; Zanichelli A; Gidaro A; Tarricone R; Cicardi M
BMJ Open; 2018 Jul; 8(7):e022291. PubMed ID: 30061443
[TBL] [Abstract][Full Text] [Related]
33. Icatibant for the treatment of hereditary angioedema.
Cole SW; Lundquist LM
Ann Pharmacother; 2013 Jan; 47(1):49-55. PubMed ID: 23249729
[TBL] [Abstract][Full Text] [Related]
34. Self-administration of icatibant in acute attacks of Type I hereditary angioedema: A case report and review of hereditary angioedema.
Piras V; Alves F; Gonçalo M
Dermatol Ther; 2019 Nov; 32(6):e13098. PubMed ID: 31579975
[TBL] [Abstract][Full Text] [Related]
35. Icatibant for the treatment of hereditary angioedema with C1-inhibitor deficiency in adolescents and in children aged over 2 years.
Farkas H; Kőhalmi KV
Expert Rev Clin Immunol; 2018 Jun; 14(6):447-460. PubMed ID: 29757016
[TBL] [Abstract][Full Text] [Related]
36. Icatibant Outcome Survey in Patients with Hereditary Angioedema: Experience in Israel Compared with Other Countries.
Toubi E; Kivity S; Graif Y; Reshef A; Botha J; Andresen I
Isr Med Assoc J; 2018 Apr; 20(4):227-232. PubMed ID: 29629730
[TBL] [Abstract][Full Text] [Related]
37. Safety, efficacy, and pharmacokinetics of icatibant treatment in Japanese pediatric patients with hereditary angioedema: A phase 3, open-label study.
Hide M; Wang Y; Dote N; Miyakawa K; Sugiura K; Ishida K
J Dermatol; 2023 Nov; 50(11):1473-1477. PubMed ID: 37381768
[TBL] [Abstract][Full Text] [Related]
38. [Administration of conestat alfa, human C1 esterase inhibitor and icatibant in the treatment of acute angioedema attacks in adults with hereditary angioedema due to C1 esterase inhibitor deficiency. Treatment comparison based on systematic review results].
Kawalec P; Holko P; Paszulewicz A; Obtułowicz K
Pneumonol Alergol Pol; 2013; 81(2):95-104. PubMed ID: 23420425
[TBL] [Abstract][Full Text] [Related]
39. Analysis of characteristics associated with reinjection of icatibant: Results from the icatibant outcome survey.
Longhurst HJ; Aberer W; Bouillet L; Caballero T; Fabien V; Zanichelli A; Maurer M;
Allergy Asthma Proc; 2015; 36(5):399-406. PubMed ID: 26314822
[TBL] [Abstract][Full Text] [Related]
40. Icatibant.
Deeks ED
Drugs; 2010; 70(1):73-81. PubMed ID: 20030426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
